Edmond DE Rothschild Holding S.A. Has $8.03 Million Holdings in Danaher Co. (NYSE:DHR)

Edmond DE Rothschild Holding S.A. trimmed its holdings in Danaher Co. (NYSE:DHR - Free Report) by 10.4% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 34,959 shares of the conglomerate's stock after selling 4,067 shares during the period. Edmond DE Rothschild Holding S.A.'s holdings in Danaher were worth $8,025,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. Heck Capital Advisors LLC acquired a new stake in Danaher during the fourth quarter valued at approximately $27,000. Decker Retirement Planning Inc. bought a new stake in shares of Danaher in the 4th quarter valued at approximately $31,000. Golden State Wealth Management LLC acquired a new stake in shares of Danaher during the 4th quarter valued at approximately $31,000. Strategic Financial Concepts LLC bought a new position in Danaher during the fourth quarter worth $31,000. Finally, Pineridge Advisors LLC boosted its holdings in Danaher by 63.3% in the fourth quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate's stock worth $34,000 after purchasing an additional 57 shares during the period. Institutional investors and hedge funds own 79.05% of the company's stock.

Danaher Price Performance

DHR traded down $16.49 during trading on Friday, reaching $181.42. The stock had a trading volume of 7,117,117 shares, compared to its average volume of 3,229,595. The stock has a 50 day moving average of $209.99 and a two-hundred day moving average of $233.99. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. The firm has a market capitalization of $129.66 billion, a price-to-earnings ratio of 34.36, a price-to-earnings-growth ratio of 2.66 and a beta of 0.86. Danaher Co. has a 1-year low of $181.20 and a 1-year high of $281.70.

Remove Ads

Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, meeting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period last year, the business earned $2.09 earnings per share. As a group, equities analysts anticipate that Danaher Co. will post 7.63 EPS for the current fiscal year.

Danaher Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be given a dividend of $0.32 per share. This is a positive change from Danaher's previous quarterly dividend of $0.27. The ex-dividend date of this dividend is Friday, March 28th. This represents a $1.28 annualized dividend and a dividend yield of 0.71%. Danaher's dividend payout ratio (DPR) is 24.24%.

Insider Transactions at Danaher

In other news, SVP Brian W. Ellis sold 5,700 shares of the firm's stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the completion of the sale, the senior vice president now directly owns 20,230 shares of the company's stock, valued at $4,534,149.90. This trade represents a 21.98 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Corporate insiders own 11.10% of the company's stock.

Analyst Ratings Changes

Several analysts have weighed in on the stock. Citigroup lowered their target price on shares of Danaher from $285.00 to $265.00 and set a "buy" rating for the company in a research note on Thursday, January 30th. Guggenheim initiated coverage on shares of Danaher in a report on Thursday, December 19th. They issued a "buy" rating and a $275.00 target price on the stock. JPMorgan Chase & Co. cut their price target on Danaher from $310.00 to $300.00 and set an "overweight" rating on the stock in a report on Tuesday, January 28th. Robert W. Baird lowered their price objective on Danaher from $277.00 to $268.00 and set an "overweight" rating for the company in a research note on Tuesday, January 28th. Finally, StockNews.com cut Danaher from a "buy" rating to a "hold" rating in a research note on Saturday, December 14th. Five investment analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the company. According to data from MarketBeat.com, Danaher currently has a consensus rating of "Moderate Buy" and a consensus price target of $278.24.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.